British Heart Foundation to Provide $1.7M for Genetic Screening of Familial Hypercholesterolaemia | GenomeWeb

NEW YORK (GenomeWeb) – The British Heart Foundation said today it is funding more than £1 million ($1.7 million) to a genetic testing program for familial hypercholesterolaemia, a condition that can shorten a patient's life by 20 to 30 years if left untreated.

The program being funded by BHF will pay for nurses to screen patients and their family members for the condition. It also will go toward extending such screening services to eight NHS Trusts across England and Scotland, BHF said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A gene-editing ban has been interpreted to include mitochondrial transfer, Technology Review reports.

In Science this week: role for epigenetic in neuronal excitability, and more.

The new Office of Research Integrity director is grappling with complaints from her staff, according to ScienceInsider.

Italian researchers link SNPs in the PDSS2 gene to coffee consumption in a new paper.